59 related articles for article (PubMed ID: 16269355)
1. Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia.
Joppa MA; Ling N; Chen C; Gogas KR; Foster AC; Markison S
Peptides; 2005 Nov; 26(11):2294-301. PubMed ID: 16269355
[TBL] [Abstract][Full Text] [Related]
2. A derivative of the melanocortin receptor antagonist SHU9119 (PG932) increases food intake when administered peripherally.
Sutton GM; Josephine Babin M; Gu X; Hruby VJ; Butler AA
Peptides; 2008 Jan; 29(1):104-11. PubMed ID: 18054119
[TBL] [Abstract][Full Text] [Related]
3. MC4-R signaling within the nucleus accumbens shell, but not the lateral hypothalamus, modulates ethanol palatability in rats.
Lerma-Cabrera JM; Carvajal F; Chotro G; Gaztañaga M; Navarro M; Thiele TE; Cubero I
Behav Brain Res; 2013 Feb; 239():51-4. PubMed ID: 23146409
[TBL] [Abstract][Full Text] [Related]
4. SHU9119 and MBP10 are biased ligands at the human melanocortin-4 receptor.
Dai HC; Ji RL; Tao YX
Biochem Pharmacol; 2024 May; ():116325. PubMed ID: 38815629
[TBL] [Abstract][Full Text] [Related]
5. Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.
Adank DN; Lunzer MM; Ericson MD; Koeperich ZM; Wilber SL; Fleming KA; Haskell-Luevano C
ACS Chem Neurosci; 2020 Oct; 11(19):3051-3063. PubMed ID: 32822157
[TBL] [Abstract][Full Text] [Related]
6. Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.
Lensing CJ; Freeman KT; Schnell SM; Speth RC; Zarth AT; Haskell-Luevano C
J Med Chem; 2019 Jan; 62(1):144-158. PubMed ID: 29669202
[TBL] [Abstract][Full Text] [Related]
7. Arcuate neuropeptide Y inhibits sympathetic nerve activity via multiple neuropathways.
Shi Z; Madden CJ; Brooks VL
J Clin Invest; 2017 Jun; 127(7):2868-2880. PubMed ID: 28628036
[TBL] [Abstract][Full Text] [Related]
8. A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH
Lensing CJ; Adank DN; Wilber SL; Freeman KT; Schnell SM; Speth RC; Zarth AT; Haskell-Luevano C
ACS Chem Neurosci; 2017 Jun; 8(6):1262-1278. PubMed ID: 28128928
[TBL] [Abstract][Full Text] [Related]
9. Ac-Trp-DPhe(p-I)-Arg-Trp-NH2, a 250-Fold Selective Melanocortin-4 Receptor (MC4R) Antagonist over the Melanocortin-3 Receptor (MC3R), Affects Energy Homeostasis in Male and Female Mice Differently.
Lensing CJ; Adank DN; Doering SR; Wilber SL; Andreasen A; Schaub JW; Xiang Z; Haskell-Luevano C
ACS Chem Neurosci; 2016 Sep; 7(9):1283-91. PubMed ID: 27385405
[TBL] [Abstract][Full Text] [Related]
10. An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.
Lensing CJ; Freeman KT; Schnell SM; Adank DN; Speth RC; Haskell-Luevano C
J Med Chem; 2016 Apr; 59(7):3112-28. PubMed ID: 26959173
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.
Ericson MD; Wilczynski A; Sorensen NB; Xiang Z; Haskell-Luevano C
J Med Chem; 2015 Jun; 58(11):4638-47. PubMed ID: 25898270
[TBL] [Abstract][Full Text] [Related]
12. Agouti-related protein segments outside of the receptor binding core are required for enhanced short- and long-term feeding stimulation.
Madonna ME; Schurdak J; Yang YK; Benoit S; Millhauser GL
ACS Chem Biol; 2012 Feb; 7(2):395-402. PubMed ID: 22129136
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and treatment of inflammatory anorexia in chronic disease.
Braun TP; Marks DL
J Cachexia Sarcopenia Muscle; 2010 Dec; 1(2):135-145. PubMed ID: 21475703
[TBL] [Abstract][Full Text] [Related]
14. Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.
Vicari D; Foy KC; Liotta EM; Kaumaya PT
J Biol Chem; 2011 Apr; 286(15):13612-25. PubMed ID: 21321115
[TBL] [Abstract][Full Text] [Related]
15. Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure.
Scarlett JM; Bowe DD; Zhu X; Batra AK; Grant WF; Marks DL
J Endocrinol; 2010 Jul; 206(1):121-30. PubMed ID: 20371568
[TBL] [Abstract][Full Text] [Related]
16. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.
Tao YX
Endocr Rev; 2010 Aug; 31(4):506-43. PubMed ID: 20190196
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia.
Jang PG; Namkoong C; Kang GM; Hur MW; Kim SW; Kim GH; Kang Y; Jeon MJ; Kim EH; Lee MS; Karin M; Baik JH; Park JY; Lee KU; Kim YB; Kim MS
J Biol Chem; 2010 Mar; 285(13):9706-9715. PubMed ID: 20097762
[TBL] [Abstract][Full Text] [Related]
18. Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice.
Weyermann P; Dallmann R; Magyar J; Anklin C; Hufschmid M; Dubach-Powell J; Courdier-Fruh I; Henneböhle M; Nordhoff S; Mondadori C
PLoS One; 2009; 4(3):e4774. PubMed ID: 19295909
[TBL] [Abstract][Full Text] [Related]
19. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.
Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R123-32. PubMed ID: 18480244
[TBL] [Abstract][Full Text] [Related]
20. Central blockade of melanocortin receptors attenuates the metabolic and locomotor responses to peripheral interleukin-1beta administration.
Whitaker KW; Reyes TM
Neuropharmacology; 2008 Mar; 54(3):509-20. PubMed ID: 18082228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
